Stryker names Spencer Stiles CEO: BTIG cuts target for Stryker stock to USD 316.00

Published on 10/15/2026 at 10:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 9.40 percent year over year to USD 6.59 billion. Stryker stock costs EUR 253.95 on October 15, 2026, 0.48 percent above the Xetra close.

Leadership change and earnings context

Stryker announced Spencer Stiles as CEO successor on October 6, 2026, effective January 1, 2027.
Second-quarter revenue reached USD 6.59 billion, up 9.40 percent year over year.
Stryker stock trades at EUR 253.95 at 10:16 a.m. CEST at Lang & Schwarz on October 15, 2026, 0.48 percent above the Xetra close of October 14, 2026.
BTIG Research cut its target from USD 358.00 to USD 316.00 on October 12, 2026.

3D-Architekturrender eines modernen verglasten Firmengebäudes mit klarer Fassade — Architektonisches 3D-Render eines modernen Glasgebäudes repräsentiert den Unternehmenssitz von Stryker Corp. US8636671013 im Medizintechnik-Bereich, Illustration mit AI erstellt.

Stryker Corp. (ISIN US8636671013) was trading at EUR 253.95 at Lang & Schwarz on October 15, 2026 at 10:16 a.m. CEST, up 0.48 percent versus the Xetra close of October 14, 2026 at EUR 252.75. On October 6, 2026, Yahoo Finance reported that Spencer Stiles would become chief executive officer on January 1, 2027, while Kevin Lobo moves to executive chair. On October 12, 2026, MarketBeat reported that BTIG Research cut its target from USD 358.00 to USD 316.00 while keeping a buy rating.

Second-quarter results set the base

Stryker's second-quarter 2026 revenue reached USD 6.59 billion, up 9.40 percent from the same quarter a year earlier. The company also reported adjusted earnings per share of USD 3.69, compared with a USD 3.49 consensus estimate, according to MarketBeat. Revenue also exceeded the USD 6.58 billion consensus figure. The operating margin was 25.00 percent in the quarter, while operating cash flow reached USD 1.26 billion.

What does the target cut signal?

BTIG's reduction places the latest target USD 42.00 below its previous level, a 11.73 percent cut. The move contrasts with the broader analyst picture: 24 firms carried a Moderate Buy consensus and an average target of USD 370.68 on October 10, 2026, according to MarketBeat. The target revisions show that execution concerns remain important even after the quarterly earnings beat.

Three milestones shape the setup

On July 30, 2026, Stryker reported second-quarter revenue of USD 6.59 billion and adjusted earnings per share of USD 3.69. On October 6, 2026, the company named Spencer Stiles as its next CEO. On October 12, 2026, BTIG Research lowered its target to USD 316.00. Together, the sequence links solid reported growth with a leadership transition and more cautious valuation assumptions.

The next date is January 1, 2027

The CEO transition is scheduled for January 1, 2027, when Stiles is set to join the board and Lobo is set to become executive chair, according to Yahoo Finance. For investors, the key issue is whether the planned handover preserves the operating momentum reflected in the 9.40 percent second-quarter revenue increase.

Euro quote stays above the Xetra close

Stryker's euro quote was EUR 253.95 at Lang & Schwarz on October 15, 2026 at 10:16 a.m. CEST, 0.48 percent above the Xetra close of October 14, 2026 at EUR 252.75. The primary listing is on the NYSE, where the stock was last quoted at USD 281.63 on October 14, 2026 at 4:00 p.m. ET.

The further course of trading is shown by the continuously updated real-time quote of Stryker stock.